Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Diferença na Ocorrência de Dor Rebote em Pacientes Submetidos à Cirurgia Sob Bloqueio Poplíteo ou Bloqueio do Tornozelo (CBFR)

Rebound Pain Occurrence in Patients Undergoing Forefoot Bone Surgery Under Popliteal Sciatic Nerve Block or Distal Sensory Ankle Block: a Randomized Clinical Trial

This single-center, prospective, randomized controlled trial compared rebound pain (RP) occurrence following popliteal sciatic nerve block versus ankle block in patients undergoing elective forefoot bone surgery.

Patients were randomized to receive one of the two ultrasound-guided, single-injection peripheral nerve block techniques, combined with standardized general anesthesia induced and maintained using propofol target-controlled infusion.

The primary objective was to compare RP incidence between the two block techniques. Secondary exploratory objectives included assessing postoperative pain trajectories and perioperative changes in skin temperature and tissue oxygen saturation as indirect indicators of local vasomotor and/or inflammatory responses.

Rebound pain was operationally defined as initially mild postoperative pain (NRS <4 at post-anesthesia care unit discharge), followed by severe pain (NRS ≥7) in the context of block resolution, typically described within 12-24 hours after block resolution. The exact interval between sensory recovery and severe pain onset was not systematically recorded.

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Descrição detalhada

This prospective, randomized, single-center controlled trial compared popliteal sciatic nerve block with ankle block in patients undergoing elective forefoot bone surgery. Participants were randomly allocated in a 1:1 ratio to either regional anesthetic technique, combined with standardized general anesthesia.

All peripheral nerve blocks were performed under ultrasound guidance before surgery using ropivacaine 0.5% with adrenaline (1:400,000) and clonidine (75 µg). Ankle blocks targeted the nerves supplying the surgical territory, while popliteal sciatic nerve blocks were supplemented by saphenous nerve blockade when required.

Before recruitment, the general anesthesia protocol was modified from the initially registered regimen involving sevoflurane maintenance to propofol target-controlled infusion for both induction and maintenance. This modification aimed to standardize anesthetic management and limit potential confounding effects on postoperative pain assessment. Sufentanil was reserved for intraoperative rescue analgesia but was not required. No intravenous ketamine, dexmedetomidine, or dexamethasone was administered.

Perioperative physiological assessments included infrared skin temperature measurements and tissue oxygen saturation monitoring using INVOS near-infrared spectroscopy on the operated and contralateral limbs. The originally planned Periflux measurements were discontinued before recruitment because the local heating required by this technique could interfere with skin temperature assessment. Preoperative hs-CRP and neutrophil-to-lymphocyte ratio measurements were performed, but the originally planned postoperative biomarker assessments were not conducted.

Postoperative analgesia was standardized using paracetamol and ibuprofen, with tramadol available as rescue medication. Patients remained hospitalized for approximately 24-48 hours, allowing clinical monitoring during sensory block regression and recovery. Follow-up assessments were conducted during hospitalization and by telephone on postoperative days 4 and 30 and at 3 months.

The study primarily compared rebound pain occurrence between the two regional anesthetic techniques. However, the exact onset of severe pain was not systematically timestamped, preventing reliable reconstruction of the originally registered 24-hour endpoint. The operational assessment and corresponding sensitivity analysis are specified in the Outcome Measures section.

Tipo de estudo

Intervencional

Inscrição (Real)

90

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Brussels, Bélgica, 1200
        • Cliniques universitaires Saint-Luc

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 75 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Any surgery of the bones of the lower limbs performed as part of a PNB associated with general anaesthesia after lower limb bone surgery
  • Patient aged between 18 and 75 years old.

Exclusion Criteria:

  • refusal to participate
  • contraindication to the use of local anesthetics
  • contraindication to the use of general anesthesia
  • contraindication to regular use of postoperative analgesics like non-steroidal anti-inflammatory drugs and paracetamol
  • cognitive disorders
  • inability to answer perioperative questionnaires (language problem).

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Outro: Popliteal sciatic nerve block

An ultrasound-guided popliteal sciatic nerve block was performed using ropivacaine 0.5% combined with adrenaline (1:400,000) and clonidine (75 μg). The popliteal block generally required 20-30 mL of local anesthetic solution. An additional ultrasound-guided saphenous nerve block was performed when indicated by the surgical territory, with total administered volumes reaching up to 40 mL. The maximum permitted ropivacaine dose was 4 mg/kg, not exceeding 300 mg.

The regional anesthesia technique was combined with standardized general anesthesia induced and maintained using propofol target-controlled infusion (TCI).

Elective forefoot bone surgery under popliteal sciatic nerve

Elective forefoot bone surgery under an ankle block

Outro: Ankle block

An ultrasound-guided ankle block was performed using 15-20 mL of ropivacaine 0.5% combined with adrenaline (1:400,000) and clonidine (75 μg). The block targeted the saphenous, superficial peroneal, deep peroneal, and tibial nerves. The maximum permitted ropivacaine dose was 4 mg/kg, not exceeding 300 mg.

The regional anesthesia technique was combined with standardized general anesthesia induced and maintained using propofol target-controlled infusion (TCI).

Elective forefoot bone surgery under popliteal sciatic nerve

Elective forefoot bone surgery under an ankle block

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Incidence of rebound pain following peripheral nerve block resolution
Prazo: During postoperative hospitalization (approximately 24-48 hours), including the period of sensory block resolution.

Rebound pain was assessed as severe postoperative pain (NRS ≥7) following initially mild pain (NRS <4) at post-anesthesia care unit discharge, in the context of peripheral nerve block resolution. Incidence was compared between popliteal sciatic nerve block and ankle block groups. A sensitivity analysis used the stricter NRS >7 threshold. The exact onset of severe pain was not systematically timestamped; therefore, the originally registered 24-hour endpoint could not be reliably reconstructed.

During postoperative hospitalization (approximately 24-48 hours), including the period of sensory block resolution.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Perioperative changes in skin temperature
Prazo: Perioperative period (before and after peripheral nerve block, at emergence from general anesthesia) and postoperative day 1 (POD1).

Skin temperature (°C) was measured using infrared thermometry on the operated and contralateral feet before and after peripheral nerve block, at emergence from general anesthesia, and on postoperative day 1. Changes over time and their association with rebound pain occurrence were explored.

Perioperative period (before and after peripheral nerve block, at emergence from general anesthesia) and postoperative day 1 (POD1).
Perioperative changes in tissue oxygen saturation
Prazo: Perioperative period (before and after peripheral nerve block, at emergence from general anesthesia) and postoperative day 1 (POD1).

Tissue oxygen saturation (%) was measured using near-infrared spectroscopy (INVOS) on the operated and contralateral feet before and after peripheral nerve block, at emergence from general anesthesia, and on postoperative day 1. Changes over time and their association with rebound pain occurrence were explored.

Perioperative period (before and after peripheral nerve block, at emergence from general anesthesia) and postoperative day 1 (POD1).
Preoperative Pain Catastrophizing Scale (PCS) score
Prazo: Preoperatively, before peripheral nerve block administration.

The Pain Catastrophizing Scale (PCS) was administered preoperatively to assess pain-related catastrophizing. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing. The PCS score was descriptively reported as a baseline patient characteristic and compared between the popliteal sciatic nerve block and ankle block groups.

Preoperatively, before peripheral nerve block administration.
Preoperative Amsterdam Preoperative Anxiety and Information Scale (APAIS) score
Prazo: Preoperatively, before peripheral nerve block administration.

The Amsterdam Preoperative Anxiety and Information Scale (APAIS) was administered preoperatively to assess anxiety and information needs related to anesthesia and surgery. The total APAIS score ranges from 6 to 30, with higher scores indicating greater preoperative anxiety and/or information needs. The total score was descriptively reported as a baseline patient characteristic and compared between the popliteal sciatic nerve block and ankle block groups.

Preoperatively, before peripheral nerve block administration.
Preoperative Central Sensitization Inventory (CSI-9) score
Prazo: Preoperatively, before peripheral nerve block administration.

The nine-item Central Sensitization Inventory (CSI-9) was administered preoperatively to assess symptoms associated with central sensitization. The total score ranges from 0 to 36, with higher scores indicating a greater burden of symptoms associated with central sensitization. The CSI-9 score was descriptively reported as a baseline patient characteristic and compared between the popliteal sciatic nerve block and ankle block groups.

Preoperatively, before peripheral nerve block administration.
Preoperative DN4 questionnaire score
Prazo: Preoperatively, before peripheral nerve block administration.

The Douleur Neuropathique en 4 Questions (DN4) questionnaire was administered preoperatively to assess neuropathic pain characteristics. The total score ranges from 0 to 10, with higher scores indicating more neuropathic pain features. A score of 4 or higher suggests a neuropathic pain component. The DN4 score was descriptively reported as a baseline patient characteristic and compared between the popliteal sciatic nerve block and ankle block groups.

Preoperatively, before peripheral nerve block administration.
Postoperative DN2 score at day 4
Prazo: Postoperative day 4.

The Douleur Neuropathique en 2 Questions (DN2) questionnaire was administered on postoperative day 4 to assess neuropathic pain symptoms. The questionnaire comprises seven items derived from the DN4, each scored as present (1) or absent (0). The total score ranges from 0 to 7, with higher scores indicating more neuropathic pain symptoms. Scores were compared between the popliteal sciatic nerve block and ankle block groups.

Postoperative day 4.
Postoperative DN2 score at day 30
Prazo: Postoperative day 30.

The Douleur Neuropathique en 2 Questions (DN2) questionnaire was administered on postoperative day 30 to assess neuropathic pain symptoms. The questionnaire comprises seven items derived from the DN4, each scored as present (1) or absent (0). The total score ranges from 0 to 7, with higher scores indicating more neuropathic pain symptoms. Scores were compared between the popliteal sciatic nerve block and ankle block groups.

Postoperative day 30.
Postoperative DN2 score at 3 months
Prazo: 3 months after surgery.

The Douleur Neuropathique en 2 Questions (DN2) questionnaire was administered three months after surgery to assess neuropathic pain symptoms. The questionnaire comprises seven items derived from the DN4, each scored as present (1) or absent (0). The total score ranges from 0 to 7, with higher scores indicating more neuropathic pain symptoms. Scores were compared between the popliteal sciatic nerve block and ankle block groups.

3 months after surgery.
Preoperative high-sensitivity C-reactive protein (hs-CRP) level
Prazo: Preoperatively, before surgery.

High-sensitivity C-reactive protein (hs-CRP) levels were measured preoperatively (mg/L) as an exploratory marker of baseline systemic inflammation. Values were descriptively compared between the popliteal sciatic nerve block and ankle block groups. Postoperative hs-CRP measurements originally planned in the study protocol were not performed.

Preoperatively, before surgery.
Preoperative neutrophil-to-lymphocyte ratio (NLR)
Prazo: Preoperatively, before surgery.

The neutrophil-to-lymphocyte ratio (NLR) was calculated from preoperative blood cell counts as an exploratory marker of baseline systemic inflammation. This dimensionless ratio was descriptively compared between the popliteal sciatic nerve block and ankle block groups. Postoperative NLR measurements originally planned in the study protocol were not performed.

Preoperatively, before surgery.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Nassim TOUIL, MD, Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

24 de abril de 2023

Conclusão Primária (Real)

7 de julho de 2025

Conclusão do estudo (Real)

7 de julho de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

17 de janeiro de 2023

Enviado pela primeira vez que atendeu aos critérios de CQ

15 de fevereiro de 2023

Primeira postagem (Real)

21 de fevereiro de 2023

Atualizações de registro de estudo

Última Atualização Postada (Real)

5 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

2 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2022/22SEP/352

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .